<!DOCTYPE html>
<html lang="fr" id="mag-chapter"><head><title>DA-NanoTrons | Results</title>
<link href="main.css" media="screen" rel="stylesheet" type="text/css" >
<link href="../favicon.ico" rel="shortcut icon" type="image/x-icon" >
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" >
<meta http-equiv="Content-Language" content="fr" > 



<style type="text/css">.nav-wrapper .secondary-nav{display:none}.tree-5 ul.tree-5{display:block}#header .tree-5 li.tree-5{opacity:1}#header .tree-5 li.tree-5
a{color:#DE0025}.tree-6 ul.tree-6{display:block}#header .tree-6 li.tree-6{opacity:1}#header .tree-6 li.tree-6
a{color:#DE0025}.tree-7 ul.tree-7{display:block}#header .tree-7 li.tree-7{opacity:1}#header .tree-7 li.tree-7
a{color:#DE0025}.tree-8 ul.tree-8{display:block}#header .tree-8 li.tree-8{opacity:1}#header .tree-8 li.tree-8
a{color:#DE0025}.tree-9 ul.tree-9{display:block}#header .tree-9 li.tree-9{opacity:1}#header .tree-9 li.tree-9
a{color:#DE0025}</style>

<!--[if lt IE 9]> <script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script> <![endif]--></head>


<body class="magazine" contenteditable="false" >
<div id="wrapper"> 

<div class="inner"> 




<section id="content">

	
	
	
<p class="description rte">
<div class="outer-mag">
<div class="mag-article grid grid-w180-g10">

<div class="header-chapter">
	<h1 class="heading-1" style="font-size:34px;">Taslimarif Saiyed</h1>
</div>



	<div class="mag-content">
		
		In his role as Director, Dr.Taslimarif Saiyed manages C-CAMP's research strategies, operations, and business worldwide. This includes management/promotion of technology facilities, strategic collaborations for new technology creation, education and training programmes, and innovation accelerator unit. Additionally, he also oversees the Intellectual Property Management Office (IPMO) and Technology Transfer Office at C-CAMP.

		Prior to joining C-CAMP, Dr. Saiyed was based in San Francisco where he was a scientist with University of California, San Francisco (UCSF), working on neurodegenerative diseases like Parkinson's disease. In the bay area, he also worked as a consultant with QB3 New Biotech Venture Consulting as well as in an individual capacity where he consulted for biotech firms in the US, providing in-depth analysis backed recommendations on market analysis, funding, IP issues, technology transfer, and competitive intelligence. He holds a doctorate in Neuroscience from Max-Planck Institute for Brain Research, Germany.
	
	
	
	</div> 


<div class="clear">&nbsp;</div></div></div></p> </section></div></div>
<div class="clear"></div> 



<script type="text/javascript" src="scripts.js"></script>
</body></html>
<!-- Localized -->